GI Dynamics is a medical device company developing therapies for the treatment of type 2 diabetes and related metabolic diseases.
GI Dynamics, Inc., a medical device company, develops therapies for the treatment of type 2 diabetes and related metabolic diseases in the United States. Its products also include EndoBarrier, a non-surgical therapy to treat type 2 diabetes and obesity. The company was founded in 2003 and is based in Lexington, Massachusetts.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 23, 2019 | Post-IPO Equity | $10M | 1 |
Crystal Amber
|
— | Detail |
| Jan 7, 2010 | Series Unknown | $15M | 1 |
Medtronic
|
— | Detail |
| Mar 2, 2009 | Series C | $15M | 2 | — | — | Detail |
| May 25, 2004 | Series B | $12M | 2 |
Cutlass Capital
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Crystal Amber
|
Yes | Post-IPO Equity |
Medtronic
|
Yes | Series Unknown |
|
|
— | Series C |
Cutlass Capital
|
— | Series C |